Annual Meeting


AGE 52nd Annual Meeting:
Integrative Approaches to Geroscience
June 2-5, 2024   |   Madison, Wisconsin USA

Important Dates:

Early Career Scholar Applications Open - Apply Here Today!
Denham Harman Award Application Due: December 1, 2023
Exceptional Mentor Award Deadline: December 1, 2023
AGE Fellow Nominations: December 1, 2023
Early Career Scholar Award Application Deadline: December 16, 2023
Early Bird Registration Ends:  February 16, 2024

Women in AGE Awards for Mentoring and Scientific Achievement Nominations: February 23, 2024
GeroScience Outstanding Publication Awards Deadline March 1, 2024

Award Consideration (Submit Your Abstract): March 8, 2024
Abstract Submission for Speakers and Posters: March 8, 2024
Standard Registration Ends: April 30, 2024
Group Rate Hotel Reservations: May 3, 2024 (Open now)
Meeting Dates: (June 8-11, 2023) June 2-5, 2024



The Madison Concourse Hotel
1 West Dayton St. Madison, WI 53703
Phone: 608 257 6000
[email protected]

Individuals are requested to call the Hotel directly at 1-800-356-8293 to make reservations. Please identify yourself as part of AGE Annual Conference or AGE Student when making your guest room reservations. Guest room rates are subject to applicable state and local taxes in effect at the time of check-in. The current tax rate is 15.5%.

Concourse Premier Room (Main Block) $189.00
Concourse Premier Student Block $165.00

Main Block:

Group Direct Booking Link

Student Block:

Group Direct Booking Link

Parking charges are based on the prevailing rate at the time of function. The current rate is $1.50 per hour, up to a maximum of $17 per day. Parking charges for overnight hotel guests are $15/night for self-park. Additional parking facilities are available across the street at the State Street Capitol ramp (214 N. Carroll Street). If your vehicle is over 6’3”, please contact the hotel for parking assistance prior to arrival.

All reservations cancelled after 4:00 p.m. C.S.T. 24 hours prior to arrival and all “no shows” will be charged one night room/tax.

Check-in time is 3:00pm and check-out time is 11:00am.


Keynote Speaker

Dr. Catherine Kaczorowski received her BA summa cum laude from University of Wisconsin-Milwaukee in 2000, received her PhD degree from Northwestern University, and received training in Physiology and Biotechnology and Bioengineering at Medical College of Wisconsin as a K99/R00 Pathway to Independence awardee. She is a Professor at The University of Michigan and the Elinor Levine Endowed Chair for Dementia Research. Dr. Kaczorowski is a neurophysiologist, an expert in the systems genetics of ‘normal’ nonpathological Aging and pathogenesis of neurodegenerative diseases including Alzheimer’s disease (AD). She has been a driving force in uncovering and describing the phenomenon of cognitive resilience in the context of ‘normal’ nonpathological aging, AD and more recently Huntington’s (HD). She is a recognized authority in the development and application of genetically diverse mouse models for studies on aging and age-related neurodegenerative disorders, and intervention testing.

Areas of interest*
Her research program entails several collaborative, multi-institutional projects and leverages the innovative, translational integration of multi-scale data (genetics, omics, imaging, behavior) from genetically diverse mouse strains and human patients to identify genetic mechanisms that promote cognitive resilience to normal brain aging, AD, and other age-related neurodegenerative diseases. Her team builds tools that permit dissection of aging specific genetic mechanisms from those controlling the clinical manifestations resulting from disease-specific neuropathologies, which is impossible in human populations. Her recent publications demonstrate the strength of her lab’s mouse-to-human research translational workflow that continues to transform the field’s ability to model resilience to normal age-related cognitive decline and AD. Taken together, these collaborative works set the foundation of the mouse genetic reference panel, the behavioral and electrophysiological assays for cognitive resilience, the systems genetics and cross-species computational analysis pipeline, and cell type-specific and regional signatures of resilience that are integral to the development of resilience-based therapies to delay or prevent cognitive aging and neurodegenerative dementias.